ACTIVE

BAUPHAR

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

220,6 k €

+140.5% YoY

Gross margin

590,4 k €

+16.8% YoY

Equity

326,3 k €

+58.7% YoY

Workforce

5,0 ETP

-10.7% YoY

What does BAUPHAR do?

BAUPHAR is a Public limited company incorporated in 2005. Its registered office is in Rebecq. It employs on average 5,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0878.246.017

Incorporation

22/12/2005

Legal form

Public limited company

Registered office

Route de Quenast 15
1430 Rebecq · WallonieSee on map

Contributed capital

130 000,00 €

Latest accounts

31/12/2025

Average workforce

5,0 ETP

Joint committees (1)

Signals

ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	590,4 k €	+16.8%	505,7 k €	-7.4%	546,1 k €	+2.0%	535,5 k €	-9.0%	588,3 k €	+3.2%	570 k €	+23.1%	463,1 k €	+3.2%	448,7 k €	-0.6%	451,4 k €	-0.7%	454,5 k €	+5.6%	430,3 k €	+8.2%	397,8 k €	-10.1%	442,6 k €	+43.0%	309,5 k €	+23.9%	249,7 k €	+13.4%	220,1 k €	-13.1%	253,2 k €	+4.3%	242,6 k €	+9.5%	221,6 k €	+17.1%	189,2 k €
EBITDA	314,7 k €	+90.5%	165,2 k €	-49.2%	324,8 k €	-6.7%	348,1 k €	-20.7%	438,8 k €	+11.3%	394,1 k €	+43.8%	274 k €	+27.4%	215,1 k €	-17.5%	260,6 k €	-7.9%	283,1 k €	+12.2%	252,2 k €	-0.8%	254,1 k €	-12.7%	291,1 k €	+59.9%	182 k €	+24.3%	146,4 k €	+39.1%	105,3 k €	-21.5%	134,1 k €	-7.2%	144,5 k €	+17.3%	123,2 k €	+51.6%	81,3 k €
Operating result	273,1 k €	+100%	136,3 k €	-55.2%	304,3 k €	-8.0%	330,7 k €	-17.8%	402,3 k €	+13.1%	355,7 k €	+51.0%	235,6 k €	+36.4%	172,7 k €	-20.0%	215,9 k €	-9.2%	237,8 k €	+34.0%	177,4 k €	+0.7%	176,3 k €	-17.4%	213,4 k €	+104%	104,8 k €	+0.4%	104,4 k €	+53.2%	68,1 k €	-29.6%	96,8 k €	-8.4%	105,7 k €	+21.8%	86,8 k €	+95.8%	44,3 k €
Net result	220,6 k €	+140%	91,7 k €	-65.6%	266,8 k €	-7.2%	287,5 k €	-15.5%	340,2 k €	+11.8%	304,2 k €	+70.2%	178,7 k €	+38.9%	128,7 k €	-23.6%	168,4 k €	-8.1%	183,3 k €	+34.0%	136,8 k €	+0.6%	135,9 k €	-14.9%	159,7 k €	+88.1%	84,9 k €	-13.0%	97,6 k €	+66.6%	58,6 k €	-30.7%	84,6 k €	-3.4%	87,5 k €	+31.3%	66,7 k €	+124%	29,8 k €
Balance sheet
Equity	326,3 k €	+58.7%	205,6 k €	-3.9%	213,9 k €	-9.8%	237,1 k €	+18.8%	199,6 k €	-20.0%	249,4 k €	-25.6%	335,2 k €	+30.7%	256,4 k €	-56.4%	587,7 k €	+13.2%	519,3 k €	+19.1%	436 k €	+15.0%	379,2 k €	+17.3%	323,3 k €	+32.7%	243,6 k €	+11.4%	218,7 k €	+6.1%	206,1 k €	+7.1%	192,5 k €	+11.3%	173 k €	+14.2%	151,5 k €	+8.3%	139,8 k €
Total assets	1,2 M €	+8.2%	1,1 M €	-17.7%	1,4 M €	+3.1%	1,4 M €	-14.5%	1,6 M €	+24.6%	1,3 M €	+9.6%	1,2 M €	-8.4%	1,3 M €	+1.9%	1,2 M €	-0.4%	1,2 M €	+8.4%	1,2 M €	+10.5%	1 M €	+1.8%	1 M €	+3.6%	987,3 k €	+112%	465,1 k €	+0.0%	464,9 k €	-20.2%	582,8 k €	+25.3%	465 k €	-4.6%	487,2 k €	+3.0%	473,2 k €
Cash	104,6 k €	-7.2%	112,7 k €	-66.1%	332,4 k €	+27.0%	261,8 k €	+45.0%	180,5 k €	-16.6%	216,5 k €	+71.2%	126,5 k €	-25.3%	169,2 k €	-23.3%	220,5 k €	+5.1%	209,8 k €	+6.8%	196,5 k €	-5.9%	208,8 k €	+52.2%	137,2 k €	-25.2%	183,4 k €	+39.3%	131,6 k €	+40.1%	93,9 k €	-42.7%	164 k €	+294%	41,6 k €	+96.8%	21,2 k €	+15.6%	18,3 k €
Debts	916,5 k €	-2.8%	942,8 k €	-20.2%	1,2 M €	+5.8%	1,1 M €	-19.2%	1,4 M €	+35.8%	1 M €	+24.0%	821,5 k €	-18.5%	1 M €	+54.0%	654,8 k €	-10.0%	727,8 k €	+2.0%	713,4 k €	+7.7%	662,4 k €	-5.2%	698,6 k €	-5.6%	740,3 k €	+200%	246,4 k €	-4.8%	258,8 k €	-33.7%	390,3 k €	+34.9%	289,2 k €	-13.7%	335,3 k €	+0.6%	333,4 k €
Other
Workforce	5,0 ETP	-10.7%	5,6 ETP	+36.6%	4,1 ETP	+13.9%	3,6 ETP	+28.6%	2,8 ETP	-20.0%	3,5 ETP	-7.9%	3,8 ETP	-28.3%	5,3 ETP	+17.8%	4,5 ETP	-2.2%	4,6 ETP	+9.5%	4,2 ETP	+40.0%	3,0 ETP	+11.1%	2,7 ETP	-3.6%	2,8 ETP	+7.7%	2,6 ETP	-16.1%	3,1 ETP	+55.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 12 ended

Active mandates

CAROLINE DE VRIESE

Managing director · since 19 septembre 2016

Active

ADV Pharma

Managing director · since 31 mars 2011 · 0833.723.215

Represented by ALINE DE VRIESE

Active

Ended mandates

CAROLINE DE VRIESE

Managing director · since 19 septembre 2016 · until 03 juin 2022

Ended

ADV Pharma

Managing director · since 31 mars 2011 · until 31 mars 2017 · 0833.723.215

Represented by ALINE DE VRIESE

Ended

ADV Pharma

Managing director · since 31 mars 2011 · until 31 mars 2017 · 0833.723.215

Represented by ALINE DE VRIESE

Ended

ADV Pharma

Managing director · since 31 mars 2011 · until 03 juin 2022 · 0833.723.215

Represented by ALINE DE VRIESE

Ended

At this address

Other companies at this address

Company	CBE no.
ADV Pharma● Active	0833.723.215
FJA● Active	0554.675.692

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	19/06/2026	11/07/2025	24/07/2024	06/07/2023	27/07/2022	06/08/2021
General meeting	05/06/2026	06/06/2025	07/06/2024	02/06/2023	03/06/2022	04/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	05/06/2026	19/06/2026	French	PDF
Abridged model	31/12/2024	06/06/2025	11/07/2025	French	PDF
Abridged model	31/12/2023	07/06/2024	24/07/2024	French	PDF
Abridged model	31/12/2022	02/06/2023	06/07/2023	French	PDF
Abridged model	31/12/2021	03/06/2022	27/07/2022	French	PDF
Abridged model	31/12/2020	04/06/2021	06/08/2021	French	PDF
Abridged model	31/12/2019	05/06/2020	23/07/2020	French	PDF
Abridged model	31/12/2018	07/06/2019	13/08/2019	French	PDF
Abridged model	31/12/2017	01/06/2018	31/07/2018	French	PDF
Abridged model	31/12/2016	02/06/2017	13/09/2017	French	PDF
Abridged model	31/12/2015	03/06/2016	30/08/2016	French	PDF
Abridged model	31/12/2014	05/06/2015	31/08/2015	French	PDF
Abridged model	31/12/2013	06/06/2014	15/07/2014	French	PDF
Abridged model	31/12/2012	07/06/2013	29/07/2013	French	PDF
Abridged model	31/12/2011	01/06/2012	24/08/2012	French	PDF
Abridged model	31/12/2010	03/06/2011	17/06/2011	French	PDF
Abridged model	31/12/2009	04/06/2010	12/07/2010	French	PDF
Abridged model	31/12/2008	05/06/2009	31/07/2009	French	PDF
Abridged model	31/12/2007	06/06/2008	29/08/2008	French	PDF
Abridged model	31/12/2006	01/06/2007	29/06/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 12 ended

Active mandates

CAROLINE DE VRIESE

Managing director · since 19 septembre 2016

Active

ADV Pharma

Managing director · since 31 mars 2011 · 0833.723.215

Represented by ALINE DE VRIESE

Active

Ended mandates

CAROLINE DE VRIESE

Managing director · since 19 septembre 2016 · until 03 juin 2022

Ended

ADV Pharma

Managing director · since 31 mars 2011 · until 31 mars 2017 · 0833.723.215

Represented by ALINE DE VRIESE

Ended

ADV Pharma

Managing director · since 31 mars 2011 · until 31 mars 2017 · 0833.723.215

Represented by ALINE DE VRIESE

Ended

ADV Pharma

Managing director · since 31 mars 2011 · until 03 juin 2022 · 0833.723.215

Represented by ALINE DE VRIESE

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates12/07/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates21/10/2016
DEMISSIONS, NOMINATIONS
PDF
Registered office24/05/2012
SIEGE SOCIAL
PDF
Mandates20/04/2011
DEMISSIONS, NOMINATIONS
PDF
Other19/01/2007
DIVERS
PDF
Mandates31/08/2006
DEMISSIONS, NOMINATIONS
PDF
Other09/01/2006
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025220,6 k €↑
2024
Annual accounts 202491,7 k €↓
2023
Annual accounts 2023266,8 k €↓
2022
Annual accounts 2022287,5 k €↓
2021
Annual accounts 2021340,2 k €↑
2020
Annual accounts 2020304,2 k €↑
2019
Annual accounts 2019178,7 k €↑
2018
Annual accounts 2018128,7 k €↓
2017
Annual accounts 2017168,4 k €↓
2016
Annual accounts 2016183,3 k €↑
2015
Annual accounts 2015136,8 k €↑
2014
Annual accounts 2014135,9 k €↓
2013
Annual accounts 2013159,7 k €↑
2012
Annual accounts 201284,9 k €↓
2011
Annual accounts 201197,6 k €↑
2010
Annual accounts 201058,6 k €↓
2009
Annual accounts 200984,6 k €↓
2008
Annual accounts 200887,5 k €↑
2007
Annual accounts 200766,7 k €↑
2006
Annual accounts 200629,8 k €
22/12/2005
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

BAUPHAR

Overview

What does BAUPHAR do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline